Topical arginase inhibition decreases growth of cutaneous squamous cell carcinoma
Abstract Cutaneous squamous cell carcinomas (cSCC) are among the most commonly diagnosed malignancies, causing significant morbidity and mortality. Tumor-associated macrophage (TAM) expression of arginase is implicated in tumor progression, and therapeutic use of arginase inhibitors has been studied...
Guardado en:
Autores principales: | Amit Mittal, Mike Wang, Aurobind Vidyarthi, Diana Yanez, Gabriela Pizzurro, Durga Thakral, Erin Tracy, Oscar R. Colegio |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/96e8c37bc01d4a76b19b76c4448d098c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Photoplethysmography for demarcation of cutaneous squamous cell carcinoma
por: Simon Mylius Rasmussen, et al.
Publicado: (2021) -
Biology and Treatment Advances in Cutaneous Squamous Cell Carcinoma
por: Alesha A. Thai, et al.
Publicado: (2021) -
Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma
por: Nader Aboul-Fettouh, et al.
Publicado: (2021) -
The landscape of driver mutations in cutaneous squamous cell carcinoma
por: Darwin Chang, et al.
Publicado: (2021) -
Risk Factors and Diagnosis of Advanced Cutaneous Squamous Cell Carcinoma
por: Gabriella Brancaccio, et al.
Publicado: (2021)